ABCC4/MRP4: a MYCN-regulated transporter and potential therapeutic target in neuroblastoma

Por Huynh, Tony, Norris, Murray D., Haber, Michelle, Henderson, Michelle J.
Publicado em 2012

Lack of correlation between MYCN expression and the Warburg effect in neuroblastoma cell lines

Por Smith, Danielle J, Cossins, Luke R, Hatzinisiriou, Irene, Haber, Michelle, Nagley, Phillip
Publicado em 2008

Use of Tumor-Specific Gene Expression for the Differential Diagnosis of Neuroblastoma from Other Pediatric Small Round-Cell Malignancies

Por Gilbert, Jayne, Haber, Michelle, Bordow, Sharon B., Marshall, Glenn M., Norris, Murray D.
Publicado em 1999

Cell-Based Methods for the Identification of MYC-Inhibitory Small Molecules

Por Burkhart, Catherine A., Haber, Michelle, Norris, Murray D., Gudkov, Andrei V., Nikiforov, Mikhail A.
Publicado no Methods Mol Biol (2013)

Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma

Por Bassiri, Hamid, Benavides, Adriana, Haber, Michelle, Gilmour, Susan K., Norris, Murray D., Hogarty, Michael D.
Publicado no Transl Pediatr (2015)

Enhancing the anti-angiogenic action of histone deacetylase inhibitors

Por Dwarte Tanya, Norris Murray D, Haber Michelle, Tee Andrew EL, Liu Tao, Kuljaca Selena, Marshall Glenn M
Publicado em 2007-10-01

Enhancing the anti-angiogenic action of histone deacetylase inhibitors

Por Kuljaca, Selena, Liu, Tao, Tee, Andrew EL, Haber, Michelle, Norris, Murray D, Dwarte, Tanya, Marshall, Glenn M
Publicado em 2007

Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma

Por Gamble, Laura D., Hogarty, Michael D., Liu, Xueyuan, Ziegler, David S., Marshall, Glenn, Norris, Murray D., Haber, Michelle
Publicado em 2012

TRIM16 overexpression induces apoptosis through activation of caspase-2 in cancer cells

Por Kim, Patrick Y., Rahmanto, Aldwin Suryo, Tan, Owen, Norris, Murray D., Haber, Michelle, Marshall, Glenn M., Cheung, Belamy B.
Publicado em 2013

Molecular profiling of childhood cancer: Biomarkers and novel therapies

Por Saletta, Federica, Wadham, Carol, Ziegler, David S., Marshall, Glenn M., Haber, Michelle, McCowage, Geoffrey, Norris, Murray D., Byrne, Jennifer A.
Publicado no BBA Clin (2014)

Opposing Effects of Two Tissue Transglutaminase Protein Isoforms in Neuroblastoma Cell Differentiation

Por Tee, Andrew E. L., Marshall, Glenn M., Liu, Pei Y., Xu, Ning, Haber, Michelle, Norris, Murray D., Iismaa, Siiri E., Liu, Tao
Publicado em 2010

HG-20 COMBINATION OF EPIGENETIC MODIFIERS CBL0137 AND PANOBINOSTAT IS HIGHLY POTENT IN VITRO AND IN VIVO FOR DIFFUSE INTRINSIC PONTINE GLIOMA

Por Ehteda, Anahid, Tsoli, Maria, Chitranjan, Arjanna, Chang, Cecilia, Simon, Sandy, Kankean, Anne, Shen, Han, Liu, Jie, Haber, Michelle, Gudkov, Andrei, Ziegler, David
Publicado no Neuro Oncol (2016)

Dextran-Catechin: An anticancer chemically-modified natural compound targeting copper that attenuates neuroblastoma growth

Por Vittorio, Orazio, Brandl, Miriam, Cirillo, Giuseppe, Kimpton, Kathleen, Hinde, Elizabeth, Gaus, Katharina, Yee, Eugene, Kumar, Naresh, Duong, Hien, Fleming, Claudia, Haber, Michelle, Norris, Murray, Boyer, Cyrille, Kavallaris, Maria
Publicado no Oncotarget (2016)

Mechanisms of embryonal tumor initiation: Distinct roles for MycN expression and MYCN amplification

Por Hansford, Loen M., Thomas, Wayne D., Keating, Joanna M., Burkhart, Catherine A., Peaston, Anne E., Norris, Murray D., Haber, Michelle, Armati, Patricia J., Weiss, William A., Marshall, Glenn M.
Publicado em 2004

Histone deacetylase 2 and N-Myc reduce p53 protein phosphorylation at serine 46 by repressing gene transcription of tumor protein 53-induced nuclear protein 1

Por Shahbazi, Jeyran, Scarlett, Christopher J., Norris, Murray D., Liu, Bing, Haber, Michelle, Tee, Andrew E., Carrier, Alice, Biankin, Andrew V., London, Wendy B., Marshall, Glenn M., Lock, Richard B., Liu, Tao
Publicado em 2014

Improving the Identification of High Risk Precursor B Acute Lymphoblastic Leukemia Patients with Earlier Quantification of Minimal Residual Disease

Por Karsa, Mawar, Dalla Pozza, Luciano, Venn, Nicola C., Law, Tamara, Shi, Rachael, Giles, Jodie E., Bahar, Anita Y., Cross, Shamira, Catchpoole, Daniel, Haber, Michelle, Marshall, Glenn M., Norris, Murray D., Sutton, Rosemary
Publicado em 2013

The long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by up-regulating pro-angiogenic gene expression

Por Tee, Andrew E., Liu, Bing, Song, Renhua, Li, Jinyan, Pasquier, Eddy, Cheung, Belamy B., Jiang, Cizhong, Marshall, Glenn M., Haber, Michelle, Norris, Murray D., Fletcher, Jamie I., Dinger, Marcel E., Liu, Tao
Publicado no Oncotarget (2016)

MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastoma

Por Lau, Diana T., Flemming, Claudia L., Gherardi, Samuele, Perini, Giovanni, Oberthuer, André, Fischer, Matthias, Juraeva, Dilafruz, Brors, Benedikt, Xue, Chengyuan, Norris, Murray D., Marshall, Glenn M., Haber, Michelle, Fletcher, Jamie I., Ashton, Lesley J.
Publicado no Oncotarget (2015)

Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis

Por Liu, Tao, Tee, Andrew E. L., Porro, Antonio, Smith, Stewart A., Dwarte, Tanya, Liu, Pei Yan, Iraci, Nunzio, Sekyere, Eric, Haber, Michelle, Norris, Murray D., Diolaiti, Daniel, Della Valle, Giuliano, Perini, Giovanni, Marshall, Glenn M.
Publicado em 2007

Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastoma

Por Cheng, Andy J., Cheng, Ngan Ching, Ford, Jette, Smith, Janice, Murray, Jayne E., Flemming, Claudia, Lastowska, Maria, Jackson, Michael S., Hackett, Christopher S., Weiss, William A., Marshall, Glenn M., Kees, Ursula R., Norris, Murray D., Haber, Michelle
Publicado em 2007